Skip to main content
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
13.94
+0.49 (3.64%)
At close: Mar 9, 2026, 4:00 PM EDT
14.00
+0.06 (0.43%)
After-hours: Mar 9, 2026, 6:31 PM EDT

TNXP Revenue

Tonix Pharmaceuticals Holding had revenue of $3.29M in the quarter ending September 30, 2025, with 16.58% growth. This brings the company's revenue in the last twelve months to $10.30M, down -8.79% year-over-year. In the year 2024, Tonix Pharmaceuticals Holding had annual revenue of $10.09M with 29.94% growth.

Revenue (ttm)
$10.30M
Revenue Growth
-8.79%
P/S Ratio
17.32
Revenue / Employee
$127,148
Employees
81
Market Cap
178.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202410.09M2.33M29.94%
Dec 31, 20237.77M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Vaxart 148.20M
Whitehawk Therapeutics 14.38M
Caribou Biosciences 11.16M
Cartesian Therapeutics 1.09M
SAB Biotherapeutics 114.70K
Revenue Rankings

TNXP News

More News